The largest database of trusted experimental protocols

Zorbax extend c18 analytical column

Manufactured by Agilent Technologies
Sourced in Canada, United States

The Zorbax Extend-C18 analytical column is a reversed-phase high-performance liquid chromatography (HPLC) column. It is designed for the separation and analysis of a wide range of organic compounds. The column features a C18 stationary phase that provides high-quality separations and reliable performance.

Automatically generated - may contain errors

6 protocols using zorbax extend c18 analytical column

1

Protein Fractionation and Digestion

Check if the same lab product or an alternative is used in the 5 most similar protocols
The samples were reduced using 5 mM TCEP for 20 min, and alkylated by 50 mM chloroacetamide for 30 min in the dark at room temperature. The proteins were first digested with endo-proteinase LysC (Roche, 11047825001, 1:100 w/w) at 35 °C for an hour. The mixture was then diluted to 2 M urea with tryptic digestion buffer (100 mM Tris-HCl, 1 mM CaCl2, pH 8.5) and the proteins were further digested by trypsin (Thermo, PRV5113, 1:20 w/w) for 20 hours at 35 °C. The resulting peptides from total crude lysate and soluble fractions were purified by STop-And-Go Extraction (STAGE) high-capacity tips using C18 resin (Phenomenex)50 (link).
Roughly 100 μg of peptides of each sample was fractionated by offline high pH reversed-phase chromatography using a Zorbax Extend-C18 analytical column, 5 μm, 4.6 × 50 mm (Agilent), on a 64 minute gradient (followed by a 21 minute equilibration with buffer A) with a 50 μL/min flow rate, where Buffer A contained 5 mM NH4HCO2, pH 10 and 2% acetonitrile and Buffer B contained 5 mM NH4HCO2, pH 10 and 90% acetonitrile. Ninety-six fractions were collected at 40 seconds/fraction. The resulting fractions were pooled in a non-contiguous manner, as previously described51 (link). The fractionated samples were pooled into 9 fractions.
+ Open protocol
+ Expand
2

Quantifying VE822 Loading in PEG-poly(PDL-co-DO) NPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
VE822-loading in PEG-poly(PDL-co-DO) NP formulations was determined using a Shimadzu HPLC System (SpectraLab Scientific, Markham, ON, Canada) with ZORBAX Extend C18 analytical column (Agilent). Briefly, 1 mL NP solution at a concentration of 1 mg mL−1 was diluted 10-fold in Acetonitrile and filtered with a 10 kDA centrifugal filter unit (Amicon). The concentration of VE822 in these samples was quantified using the high-performance liquid chromatography (HPLC) apparatus (Agilent LCMS Q ESMS 6120B) equipped with an Eclipse Plus C18 (4.6 × 50 mm, 1.8 μm, 600 bar) column. The eluent, acetonitrile/diH2O 60/40 (v/v) containing 0.1% trifluoroacetic acid (TFA), was set at a flow rate of 1 mL min−1 and the detector set at 309 nm. Standard curves were established using known drug concentrations processed (diluted and filtered) identically to the experimental samples. These curves were then used to determine the corresponding concentrations of VE822 in the experimental samples.
+ Open protocol
+ Expand
3

Cephapirin Quantification in Biological Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cephapirin was analyzed using Agilent 1290 UPLC coupled with Agilent 6490 Triple Quad tandem mass spectrometry (Agilent, Santa Clara, CA, USA). Electrospray negative ionization in multiple-reaction monitoring mode was used. Zorbax Extend C18 analytical column (4.6×50 mm, 5 µm particle size, Agilent, Santa Clara, CA, USA) coupled with Zorbax Extend C18 guard column (4.6×12 mm, 5 µm particle size, Agilent, Santa Clara, CA, USA) was used for chromatographic separation. Sampler and column compartments were kept at 8 and 40°C, respectively. The injection volume was 10 µL. A gradient elution program consisting of two mobile phases (mobile phase A: 0.1% FA in water; mobile phase B: 0.1% FA in MeOH; Table 2) was used at a flow rate of 0.5 mL min−1. Mass spectrometry parameters are listed in Table 3. Cephapirin in positive and spiked samples were qualified by comparing LC-MS/MS spectra of samples with those of cephapirin standards. Accepted variation in mass to charge ratio was 10%, and acceptable variation was set as 20% for the ratio of qualifier and quantifier ions. Cephapirin concentration in tested samples was quantified using the calibration curve of seven matrix-matched cephapirin standards (0.7, 1, 2, 4, 5, 10, and 20 µg L−1 matrix solution). Matrix-match standards were prepared using the SPE cleaned-up extracts of blank feces or urine samples.
+ Open protocol
+ Expand
4

Quantifying Lipid Oxidation Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipid oxidation products were estimated by assessing the level of as 8-isoPGF by LC MS/MS (LCMS 8060, Shimadzu, Kioto, Japan) [35 (link)] and 4-HNE by GC MS/MS [36 (link)]. 8-isoPGF was separated on an Agilent Zorbax Extend-C18 analytical column (2.1 × 50 mm, 1.8 µm particle size). Sample was isolated using solid phase extraction (SPE) method. Electrospray ionization (ESI) in negative mode was used for multiple reaction monitoring (MRM) and quantification of 8-isoPGF. 8-isoPGF–d4 was used as internal standards for quantification. The precursor to the product ion transition was as follows: m/z 353.2→193.1 for 8-isoPGF2α and 357.2→197.1 for 8-isoPGF2α-d4. 4-HNE was analyzed using a 7890 A GC–7000 quadruple MS/MS (Agilent Technologies, Palo Alto, CA USA) equipped with an HP-5 ms capillary column (0.25 mm internal diameter, 0.25 µm film thickness, 30 m length). 4-HNE was derivatized by the addition of O-(2,3,4,5,6-pentafluoro-benzyl) hydroxylamine hydrochloride (PFBHA-HCl) and detected by the selected ion-monitoring (SIM) mode. Quantitation was achieved using an internal standard (benzaldehyde-D6). The ions used were: m/z 333.0 and 181.0 for 4-HNE-PFB-TMS and m/z 307.0 for IS (benzaldehyde-D6) derivatives. Levels of 8-iso PGF and 4-HNE were expressed in pg/mg tissue.
+ Open protocol
+ Expand
5

Solid-Phase Extraction and UPLC-MS/MS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Solid phase extraction vacuum manifold and OASIS HLB (hydrophilic-lipophilic-balanced) plus short cartridge (250 mg sorbent), used for sample clean-up, were obtained from Agilent (Lexington, MA) and Waters (Milford, MA), respectively. Analyte separation and quantification were performed using Agilent 1290 UPLC coupled with Agilent 6490 Triple Quad tandem mass spectrometry (Agilent, Santa Clara, CA). Analytical (Zorbax Extend C18 analytical column; 4.6×50 mm, 5 µm particle size) and guard columns (Zoebax Extend C18 guard column; 4.6×12 mm, 5 µm particle size) were purchased from Agilent.
+ Open protocol
+ Expand
6

Peptide Fractionation and MS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The desalted peptides from each TMT set were dissolved in 900 μL of 5 mM ammonium formate (pH 10) and 2% acetonitrile (ACN) and fractionated with a 4.6 mmx 250 mm Zorbax Extend-C18 analytical column (3.5 μm beads, Agilent) lined up with an Agilent 1220 Series HPLC. Buffer A and B were 5 mM ammonium formate in 2% ACN (pH 10) and 5 mM ammonium formate in 90% ACN, respectively. Peptides were separated by using a non-linear gradient: 0% buffer B (7 min), 0% to 16% buffer B (6 min), 16% to 40% buffer B (60 min), 40% to 44% buffer B (4 min), 44% to 60% buffer B (5 min) and then held at 60% buffer B for 14 min. The flow rate was set at 1 mL/min. Collected fractions were concatenated into 24 fractions as described previously. (Mertins et al., 2018 (link)) Eight percent of each of the 24 fractions was aliquoted, cleaned up with strong cation exchange (SCX) stage tip, and dried in a Speed-Vac. Samples were resuspended in 3% ACN, 0.1% FA prior to ESI-LC-MS/MS analysis. The remaining sample was utilized for phosphopeptide enrichment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!